CLINICAL_TRIALS trial_result · 2014-09-23

Clinical Trial Update: A Phase 3 Study of Ranolazine in Subjects With Type 2 Diabetes Who Are Inadequately Controlled on Metformin Alone [Phase 3]

Phase 3 study of ranolazine in adults with type 2 diabetes inadequately controlled on metformin completed; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Gilead Sciences | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2014-09-23